Article
Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks…
Therapeutics and Clinical Risk Management · 2020 · Taghy N, Cambon L, Cohen JM, Dussart C
Key facts
| Title | Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts—Results of a Literature Review |
|---|---|
| First author | Taghy N, Cambon L, Cohen JM, Dussart C |
| Journal | Therapeutics and Clinical Risk Management |
| Published | Feb 11, 2020 |
| DOI | 10.2147/TCRM.S214187 |
| Devices mentioned | 214187 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1